Patent · US Active

Engineered polypeptides

US11732023B2 · kind B2 · utility

0Cited by
19References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 17, 2019
Grant dateAug 22, 2023
Priority date
Expiry dateMar 27, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/70
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Provided herein are polypeptides that bind to a blood-brain barrier (BBB) receptor, methods of generating such polypeptides, and methods of using the polypeptides to target a composition to a BBB receptor-expressing cell, e.g., for transport across the BBB. Also provided herein are transferrin receptor (TfR) constructs that comprise a monomeric TfR apical domain or one or more portions of the TfR apical domain which have been circularly permuted relative to the full-length TfR sequence.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.